BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27448963)

  • 1. CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin.
    Kendall JJ; Chaney KE; Patel AV; Rizvi TA; Largaespada DA; Ratner N
    Oncotarget; 2016 Aug; 7(33):53191-53203. PubMed ID: 27448963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.
    Dodd RD; Mito JK; Eward WC; Chitalia R; Sachdeva M; Ma Y; Barretina J; Dodd L; Kirsch DG
    Mol Cancer Ther; 2013 Sep; 12(9):1906-17. PubMed ID: 23858101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decorin suppresses stemness and migration potential of malignant peripheral nerve sheath tumor through inhibiting epidermal growth factor receptor signaling.
    Jia X; Chen L; Yu C
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167181. PubMed ID: 38653361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors.
    Borcherding DC; Amin NV; He K; Zhang X; Lyu Y; Dehner C; Bhatia H; Gothra A; Daud L; Ruminski P; Pratilas CA; Pollard K; Sundby T; Widemann BC; Hirbe AC
    Clin Cancer Res; 2023 Apr; 29(8):1592-1604. PubMed ID: 36799629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumoral activity of allosteric inhibitors of protein kinase CK2.
    Moucadel V; Prudent R; Sautel CF; Teillet F; Barette C; Lafanechere L; Receveur-Brechot V; Cochet C
    Oncotarget; 2011 Dec; 2(12):997-1010. PubMed ID: 22184283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ral A, via activating the mitotic checkpoint, sensitizes cells lacking a functional Nf1 to apoptosis in the absence of protein kinase C.
    Ganapathy S; Fagman JB; Shen L; Yu T; Zhou X; Dai W; Makriyannis A; Chen C
    Oncotarget; 2016 Dec; 7(51):84326-84337. PubMed ID: 27741517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor.
    Lemberg KM; Zhao L; Wu Y; Veeravalli V; Alt J; Aguilar JMH; Dash RP; Lam J; Tenora L; Rodriguez C; Nedelcovych MT; Brayton C; Majer P; Blakeley JO; Rais R; Slusher BS
    Mol Cancer Ther; 2020 Feb; 19(2):397-408. PubMed ID: 31594823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo.
    Kohlmeyer JL; Kaemmer CA; Lingo JJ; Voigt E; Leidinger MR; McGivney GR; Scherer A; Koppenhafer SL; Gordon DJ; Breheny P; Meyerholz DK; Tanas MR; Dodd RD; Quelle DE
    Neurooncol Adv; 2022; 4(1):vdac047. PubMed ID: 35571990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting IL-13Rα2 for effective treatment of malignant peripheral nerve sheath tumors in mouse models.
    Mrowczynski OD; Payne RA; Bourcier AJ; Mau CY; Slagle-Webb B; Shenoy G; Madhankumar AB; Abramson SB; Wolfe D; Harbaugh KS; Rizk EB; Connor JR
    J Neurosurg; 2018 Nov; 131(5):1369-1379. PubMed ID: 30544352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior.
    López-Juárez A; Titus HE; Silbak SH; Pressler JW; Rizvi TA; Bogard M; Bennett MR; Ciraolo G; Williams MT; Vorhees CV; Ratner N
    Cell Rep; 2017 Apr; 19(3):545-557. PubMed ID: 28423318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia.
    Quotti Tubi L; Canovas Nunes S; Brancalion A; Doriguzzi Breatta E; Manni S; Mandato E; Zaffino F; Macaccaro P; Carrino M; Gianesin K; Trentin L; Binotto G; Zambello R; Semenzato G; Gurrieri C; Piazza F
    Leukemia; 2017 Feb; 31(2):292-300. PubMed ID: 27479180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Anti-Angiogenesis Therapy in Colorectal Cancer.
    Ciombor KK; Goldberg RM
    Curr Colorectal Cancer Rep; 2015 Dec; 11(6):378-387. PubMed ID: 27551256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma.
    Del Mare S; Husanie H; Iancu O; Abu-Odeh M; Evangelou K; Lovat F; Volinia S; Gordon J; Amir G; Stein J; Stein GS; Croce CM; Gorgoulis V; Lian JB; Aqeilan RI
    Cancer Res; 2016 Oct; 76(20):6107-6117. PubMed ID: 27550453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer.
    Spolverato G; Bagante F; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Winslow E; Cho C; Martin RC; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
    World J Surg; 2017 Jan; 41(1):224-231. PubMed ID: 27549595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs to predict survival in acute myeloid leukemia: a step toward personalized medicine?
    Bhatnagar B; Garzon R
    Biomark Med; 2016 Sep; 10(9):935-8. PubMed ID: 27548737
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumors Alter Inflammation and Impair Dermal Wound Healing in Female Mice.
    Pyter LM; Husain Y; Calero H; McKim DB; Lin HY; Godbout JP; Sheridan JF; Engeland CG; Marucha PT
    PLoS One; 2016; 11(8):e0161537. PubMed ID: 27548621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration of our understanding of recurrent acute and chronic pancreatitis.
    Pandol SJ; Forsmark CE; Hart PA;
    Pancreatology; 2016; 16(5):692-3. PubMed ID: 27542963
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic variants in thyroid cancer distant metastases.
    Justiniano SE; McElroy JP; Yu L; Yilmaz AS; Coombes KR; Senter L; Nagy R; Wakely P; Volinia S; Vinco M; Giordano TJ; Croce CM; Saji M; Ringel MD
    Endocr Relat Cancer; 2016 Oct; 23(10):L33-6. PubMed ID: 27542854
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous mantle cell lymphoma: a clinicopathologic review of 10 cases.
    Gru AA; Hurley MY; Salavaggione AL; Brodell L; Sheinbein D; Anadkat M; Porcu P; Frater JL
    J Cutan Pathol; 2016 Dec; 43(12):1112-1120. PubMed ID: 27539965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual differences in physical symptom burden and psychological responses in individuals with chronic lymphocytic leukemia.
    Morrison EJ; Flynn JM; Jones J; Byrd JC; Andersen BL
    Ann Hematol; 2016 Dec; 95(12):1989-1997. PubMed ID: 27539615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.